| close window |
| Tuesday, April 29, 2008 |
|
Medco Health 1Q profit, sales top Wall Street estimates
Net income slipped to $270.2 million, or 50 cents per share, from $274.8 million, or 47 cents per share, a year ago, when a generic version of blood thinner Plavix was briefly on the market. But excluding amortization costs, earnings per share totaled 55 cents in the latest period, up from 52 cents last year. Revenue grew 16 percent to $12.96 billion from $11.16 billion, as price inflation on brand-name drugs and higher volumes associated with new client wins offset higher generic dispensing rates. Generic drug sales contribute less to overall revenue but boost profit margins. Analysts surveyed by Thomson Financial expected profit before one-time items of 53 cents per share on revenue of $12.26 billion. The company said mail-order prescription volume increased 13.7 percent to 26.6 million, while retail prescription volume increased 6.4 percent to 127.2 million. Medco Health Solutions Inc. reaffirmed its outlook for 2008 adjusted profit between $2.27 and $2.31 per share. Analysts expect full-year earnings per share of $2.30. ------- AP Business Writer Jennifer Malloy 2008-04-29 11:09:34 GMT
|
|
Copyright 2008 The Associated Press All Rights Reserved The information contained in the AP News report may not be published, broadcast, rewritten or redistributed without the prior written authorityof The Associated Press. |
| close window |